Metabolomics of ADSOL (AS-1) red blood cell storage

Transfusion Medicine Reviews

Volumn 28, Issue 2, 2014, Pages 41-55

  Roback, John D ^a   Josephson, Cassandra D ^a   Waller, Edmund K ^a   Newman, James L ^a   Karatela, Sulaiman ^a   Uppal, Karan ^a   Jones, Dean P ^a   Zimring, James C ^b   Dumont, Larry J ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PUGET SOUND BLOOD CENTER   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; 6 PHOSPHOFRUCTOKINASE; ADENINE; DIHYDROXYACETONE PHOSPHATE; FRUCTOSE 1,6 BISPHOSPHATE; FRUCTOSE 6 PHOSPHATE; GLUCOSE; GLUTATHIONE; GLYCERALDEHYDE 3 PHOSPHATE; HEMOGLOBIN; LACTIC ACID; MANNITOL; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PYRUVIC ACID; SODIUM CHLORIDE; ADSOL; LIPID;

ARTICLE; BLOOD BANK; BLOOD DONOR; ERYTHROCYTE PRESERVATION; GLYCOLYSIS; HUMAN; INTERNALIZATION; MASS FRAGMENTOGRAPHY; METABOLISM; METABOLITE; METABOLOMICS; NEGATIVE FEEDBACK; NORMAL HUMAN; NUCLEOTIDE METABOLISM; OXIDATIVE STRESS; PENTOSE PHOSPHATE CYCLE; TANDEM MASS SPECTROMETRY; UREA CYCLE; ANIMAL; BLOOD STORAGE; C57BL MOUSE; CELL MEMBRANE; CHEMISTRY; CYTOLOGY; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; KINETICS; LIQUID CHROMATOGRAPHY; METABOLOME; MOUSE; PROCEDURES; SIGNAL TRANSDUCTION;

ADENINE; ANIMALS; BLOOD PRESERVATION; CELL MEMBRANE; CHROMATOGRAPHY, LIQUID; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLUCOSE; GLYCOLYSIS; HUMANS; KINETICS; LIPIDS; MANNITOL; METABOLOME; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; SODIUM CHLORIDE; TANDEM MASS SPECTROMETRY;

EID: 84899478601     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2014.01.003     Document Type: Article

References (71)

1. Hovav T., Yedgar S., Manny N., Barshtein G. Alteration of red cell aggregability and shape during blood storage. Transfusion 1999, 39(3):277-281.
2. Hess J.R. An update on solutions for red cell storage. Vox Sang 2006, 91(1):13-19.
3. Bosman G.J., Lasonder E., Luten M., Roerdinkholder-Stoelwinder B., Novotny V.M., Bos H., et al. The proteome of red cell membranes and vesicles during storage in blood bank conditions. Transfusion 2008, 48(5):827-835.
4. Donadee C., Raat N.J., Kanias T., Tejero J., Lee J.S., Kelley E.E., et al. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 2011, 124(4):465-476.
5. Rinalducci S., D'Amici G.M., Blasi B., Zolla L. Oxidative stress-dependent oligomeric status of erythrocyte peroxiredoxin II (PrxII) during storage under standard blood banking conditions. Biochimie 2011, 93(5):845-853.
6. Tinmouth A., Fergusson D., Yee I.C., Hebert P.C. Clinical consequences of red cell storage in the critically ill. Transfusion 2006, 46(11):2014-2027.
7. Koch C.G., Li L., Sessler D.I., Figueroa P., Hoeltge G.A., Mihaljevic T., et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008, 358(12):1229-1239.
8. Roback J.D., Neuman R.B., Quyyumi A., Sutliff R. Insufficient nitric oxide bioavailability: a hypothesis to explain adverse effects of red blood cell transfusion. Transfusion 2011, 51(4):859-866.
9. Dumont L.J., AuBuchon J.P. Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials. Transfusion 2008, 48(6):1053-1060.
10. Klein H.G., Anstee D.J. Mollison's blood transfusion in clinical medicine 2005, Blackwell Publishing Inc., Malden Massachusetts. 11th ed.
11. Sparrow R.L. Time to revisit red blood cell additive solutions and storage conditions: a role for "omics" analyses. Blood Transfus 2012, 10(Suppl 2):s7-s11.
12. Cluitmans J.C., Hardeman M.R., Dinkla S., Brock R., Bosman G.J. Red blood cell deformability during storage: towards functional proteomics and metabolomics in the blood bank. Blood Transfus 2012, 10(Suppl 2):s12-s18.
13. Jamshidi N., Palsson B.O. Systems biology of the human red blood cell. Blood Cells Mol Dis 2006, 36(2):239-247.
14. Nishino T., Yachie-Kinoshita A., Hirayama A., Soga T., Suematsu M., Tomita M. In silico modeling and metabolome analysis of long-stored erythrocytes to improve blood storage methods. J Biotechnol 2009, 144(3):212-223.
15. Bordbar A., Jamshidi N., Palsson B.O. iAB-RBC-283: a proteomically derived knowledge-base of erythrocyte metabolism that can be used to simulate its physiological and patho-physiological states. BMC Syst Biol 2011, 5:110.
16. Fergusson D.A., Hebert P., Hogan D.L., LeBel L., Rouvinez-Bouali N., Smyth J.A., et al. Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial. JAMA 2012, 308(14):1443-1451.
17. Gevi F., D'Alessandro A., Rinalducci S., Zolla L. Alterations of red blood cell metabolome during cold liquid storage of erythrocyte concentrates in CPD-SAGM. J Proteomics 2012, 76:168-180.
18. Alexander J.T., El-Ali A.M., Newman J.L., Karatela S., Predmore B.L., Lefer D.J., et al. Red blood cells stored for increasing periods produce progressive impairments in nitric oxide-mediated vasodilation. Transfusion 2013, 53(11):2619-2628.
19. Hess J.R., Greenwalt T.G. Storage of red blood cells: new approaches. Transfus Med Rev 2002, 16(4):283-295.
20. Zimrin A.B., Hess J.R. Current issues relating to the transfusion of stored red blood cells. Vox Sang 2009, 96(2):93-103.
21. Messana I., Misiti F., el-Sherbini S., Giardina B., Castagnola M. Quantitative determination of the main glucose metabolic fluxes in human erythrocytes by 13C- and 1H-MR spectroscopy. J Biochem Biophys Methods 1999, 39(1-2):63-84.
22. Messana I., Ferroni L., Misiti F., Girelli G., Pupella S., Castagnola M., et al. Blood bank conditions and RBCs: the progressive loss of metabolic modulation. Transfusion 2000, 40(3):353-360.
23. Kuchel P.W., Philp D.J. Isotopomer subspaces as indicators of metabolic-pathway structure. J Theor Biol 2008, 252(3):391-401.
24. Francis R.O., Jhang J.S., Pham H.P., Hod E.A., Zimring J.C., Spitalnik S.L. Glucose-6-phosphate dehydrogenase deficiency in transfusion medicine: the unknown risks. Vox Sang 2013, 105(4):271-282.
25. Cappellini M.D., Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet 2008, 371(9606):64-74.
26. Francis R.O., Jhang J., Hendrickson J.E., Zimring J.C., Hod E.A., Spitalnik S.L. Frequency of glucose-6-phosphate dehydrogenase-deficient red blood cell units in a metropolitan transfusion service. Transfusion 2012, 53(3):606-611.
27. Baysal E., Rice-Evans C. Modulation of iron-mediated oxidant damage in erythrocytes by cellular energy levels. Free Radic Res Commun 1987, 3(1-5):227-232.
28. Rice-Evans C., Baysal E. Iron-mediated oxidative stress in erythrocytes. Biochem J 1987, 244(1):191-196.
29. Geenen S., Taylor P.N., Snoep J.L., Wilson I.D., Kenna J.G., Westerhoff H.V. Systems biology tools for toxicology. Arch Toxicol 2012, 86(8):1251-1271.
30. Reed M.C., Thomas R.L., Pavisic J., James S.J., Ulrich C.M., Nijhout H.F. A mathematical model of glutathione metabolism. Theor Biol Med Model 2008, 5:8.
31. Richman P.G., Meister A. Regulation of gamma-glutamyl-cysteine synthetase by nonallosteric feedback inhibition by glutathione. J Biol Chem 1975, 250(4):1422-1426.
32. Raftos J.E., Whillier S., Kuchel P.W. Glutathione synthesis and turnover in the human erythrocyte: alignment of a model based on detailed enzyme kinetics with experimental data. J Biol Chem 2010, 285(31):23557-23567.
33. Mills B.J., Lang C.A. Differential distribution of free and bound glutathione and cyst(e)ine in human blood. Biochem Pharmacol 1996, 52(3):401-406.
34. Whillier S., Raftos J.E., Sparrow R.L., Kuchel P.W. The effects of long-term storage of human red blood cells on the glutathione synthesis rate and steady-state concentration. Transfusion 2011, 51(7):1450-1459.
35. Kiessling K., Roberts N., Gibson J.S., Ellory J.C. A comparison in normal individuals and sickle cell patients of reduced glutathione precursors and their transport between plasma and red cells. Hematol J 2000, 1(4):243-249.
36. Richie J.P., Abraham P., Leutzinger Y. Long-term stability of blood glutathione and cysteine in humans. Clin Chem 1996, 42(7):1100-1105.
37. Whillier S., Garcia B., Chapman B.E., Kuchel P.W., Raftos J.E. Glutamine and alpha-ketoglutarate as glutamate sources for glutathione synthesis in human erythrocytes. FEBS J 2011, 278(17):3152-3163.
38. Geenen S., Michopoulos F., Kenna J.G., Kolaja K.L., Westerhoff H.V., Wilson I. HPLC-MS/MS methods for the quantitative analysis of ophthalmic acid in rodent plasma and hepatic cell line culture medium. J Pharm Biomed Anal 2011, 54(5):1128-1135.
39. Soga T., Baran R., Suematsu M., Ueno Y., Ikeda S., Sakurakawa T., et al. Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. J Biol Chem 2006, 281(24):16768-16776.
40. D'Alessandro A., Righetti P.G., Zolla L. The red blood cell proteome and interactome: an update. J Proteome Res 2010, 9(1):144-163.
41. D'Alessandro A., D'Amici G.M., Vaglio S., Zolla L. Time-course investigation of SAGM-stored leukocyte-filtered red blood cell concentrates: from metabolism to proteomics. Haematologica 2012, 97(1):107-115.
42. Linseisen J., Wolfram G., Miller A.B. Plasma 7beta-hydroxycholesterol as a possible predictor of lung cancer risk. Cancer Epidemiol Biomarkers Prev 2002, 11(12):1630-1637.
43. Strunecka A., Folk P. Phospholipid biosynthesis in mature human erythrocytes. Gen Physiol Biophys 1988, 7(2):205-216.
44. Tehlivets O., Malanovic N., Visram M., Pavkov-Keller T., Keller W. S-adenosyl-L-homocysteine hydrolase and methylation disorders: yeast as a model system. Biochim Biophys Acta 2013, 1832(1):204-215.
45. Nishibe H. Urea cycle enzymes in human erythrocytes. Clin Chim Acta 1974, 50:305-310.
46. Schuster S., Kenanov D. Adenine and adenosine salvage pathways in erythrocytes and the role of S-adenosylhomocysteine hydrolase. A theoretical study using elementary flux modes. FEBS J 2005, 272(20):5278-5290.
47. Roede J.R., Uppal K., Park Y., Lee K., Tran V., Walker D., et al. Serum metabolomics of slow vs. rapid motor progression Parkinson's disease: a pilot study. PLoS One 2013, 8(10):e77629.
48. Uppal K., Soltow Q.A., Strobel F.H., Pittard W.S., Gernert K.M., Yu T., et al. xMSanalyzer: automated pipeline for improved feature detection and downstream analysis of large-scale, non-targeted metabolomics data. BMC Bioinforma 2013, 14:15.
49. Rogers S.C., Ross J.G., d'Avignon A., Gibbons L.B., Gazit V., Hassan M.N., et al. Sickle hemoglobin disturbs normal coupling among erythrocyte O2 content, glycolysis, and antioxidant capacity. Blood 2013, 121(9):1651-1662.
50. Meyer E.K., Dumont D.F., Baker S., Dumont L.J. Rejuvenation capacity of red blood cells in additive solutions over long-term storage. Transfusion 2011, 51(7):1574-1579.
51. Dumont L.J., Herschel L., Roback J.D., Zimring J.C., Gray A.D. Changes in the metabolomic profiles of stored RBC following treatment with Rejuvesol® Solution. Transfusion 2012, 52:78A. [Suppl].
52. Lang C.A., Mills B.J., Mastropaolo W., Liu M.C. Blood glutathione decreases in chronic diseases. J Lab Clin Med 2000, 135(5):402-405.
53. Raftos J.E., Whillier S., Chapman B.E., Kuchel P.W. Kinetics of uptake and deacetylation of N-acetylcysteine by human erythrocytes. Int J Biochem Cell Biol 2007, 39(9):1698-1706.
54. Berkeley L.I., Cohen J.F., Crankshaw D.L., Shirota F.N., Nagasawa H.T. Hepatoprotection by L-cysteine-glutathione mixed disulfide, a sulfhydryl-modified prodrug of glutathione. J Biochem Mol Toxicol 2003, 17(2):95-97.
55. Stowell S.R., Smith N.H., Zimring J.C., Fu X., Palmer A.F., Fontes J., et al. Addition of ascorbic acid solution to stored murine red blood cells increases posttransfusion recovery and decreases microparticles and alloimmunization. Transfusion 2013, 53(10):2248-2257.
56. Obeid R., Herrmann W. Homocysteine and lipids: S-adenosyl methionine as a key intermediate. FEBS Lett 2009, 583(8):1215-1225.
57. Perna A.F., Ingrosso D., Zappia V., Galletti P., Capasso G., De Santo N.G. Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure. Evidence for high levels of the natural inhibitor S-adenosylhomocysteine. J Clin Invest 1993, 91(6):2497-2503.
58. Upchurch G.R., Welch G.N., Loscalzo J. Homocysteine, EDRF, and endothelial function. J Nutr 1996, 126(4 Suppl):1290S-1294S.
59. Crawford J.H., Isbell T.S., Huang Z., Shiva S., Chacko B.K., Schechter A.N., et al. Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation. Blood 2006, 107(2):566-574.
60. Cortese-Krott M.M., Rodriguez-Mateos A., Sansone R., Kuhnle G.G., Thasian-Sivarajah S., Krenz T., et al. Human red blood cells at work: identification and visualization of erythrocytic eNOS activity in health and disease. Blood 2012, 120(20):4229-4237.
61. Webb A.J., Milsom A.B., Rathod K.S., Chu W.L., Qureshi S., Lovell M.J., et al. Mechanisms underlying erythrocyte and endothelial nitrite reduction to nitric oxide in hypoxia: role for xanthine oxidoreductase and endothelial nitric oxide synthase. Circ Res 2008, 103(9):957-964.
62. Kleinbongard P., Schulz R., Rassaf T., Lauer T., Dejam A., Jax T., et al. Red blood cells express a functional endothelial nitric oxide synthase. Blood 2006, 107(7):2943-2951.
63. Bor-Kucukatay M., Wenby R.B., Meiselman H.J., Baskurt O.K. Effects of nitric oxide on red blood cell deformability. Am J Physiol Heart Circ Physiol 2003, 284(5):H1577-H1584.
64. Kanias T., Wang L., Lippert A., Kim-Shapiro D.B., Gladwin M.T. Red blood cell endothelial nitric oxide synthase does not modulate red blood cell storage hemolysis. Transfusion 2013, 53(5):981-989.
65. Simmonds H.A., Fairbanks L.D., Duley J.A., Morris G.S. ATP formation from deoxyadenosine in human erythrocytes: evidence for a hitherto unidentified route involving adenine and S-adenosylhomocysteine hydrolase. Biosci Rep 1989, 9(1):75-85.
66. Rinalducci S., D'Amici G.M., Blasi B., Vaglio S., Grazzini G., Zolla L. Peroxiredoxin-2 as a candidate biomarker to test oxidative stress levels of stored red blood cells under blood bank conditions. Transfusion 2011, 51(7):1439-1449.
67. Hendrickson J.E., Chadwick T.E., Roback J.D., Hillyer C.D., Zimring J.C. Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. Blood 2007, 110(7):2736-2743.
68. Hod E.A., Cadwell C.M., Liepkalns J.S., Zimring J.C., Sokol S.A., Schirmer D.A., et al. Cytokine storm in a mouse model of IgG-mediated hemolytic transfusion reactions. Blood 2008, 112(3):891-894.
69. Zimring J.C., Hair G.A., Chadwick T.E., Deshpande S.S., Anderson K.M., Hillyer C.D., et al. Nonhemolytic antibody-induced loss of erythrocyte surface antigen. Blood 2005, 106(3):1105-1112.
70. Zimring J.C., Smith N., Stowell S.R., Johnsen J.M., Bell L.N., Francis R.O., et al. Strain-specific red blood cell storage, metabolism, and eicosanoid generation in a mouse model. Transfusion 2013, 54(1):137-148.
71. Zimring J.C., Spitalnik S.L. On the appropriate use and interpretation of animal models in transfusion medicine research. Transfusion 2013, 53(10):2334-2339.